Financial Security Advisor’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Hold
2,264
0.06% 118
2026
Q1
$346K Hold
2,264
0.06% 111
2025
Q4
$312K Buy
2,264
+5
+0.2% +$655 0.06% 118
2025
Q3
$290K Hold
2,259
0.06% 113
2025
Q2
$273K Hold
2,259
0.06% 104
2025
Q1
$252K Hold
2,259
0.06% 104
2024
Q4
$220K Hold
2,259
0.06% 108
2024
Q3
$260K Hold
2,259
0.06% 91
2024
Q2
$240K Hold
2,259
0.08% 94
2024
Q1
$219K Hold
2,259
0.08% 100
2023
Q4
$228K Hold
2,259
0.09% 86
2023
Q3
$230K Buy
+2,259
New +$229K 0.11% 85

Other funds holding NVS

Financial Security Advisor's NVS Position: Q2 2026 in Review

Financial Security Advisor held its Novartis (NVS) position steady in Q2 2026 at 2,264 shares worth $355K. The position accounts for 0.06% of the portfolio, ranked #118.

Financial Security Advisor first reported a position in NVS in Q3 2023 and has held it in 12 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Financial Security Advisor held 2,264 shares of Novartis worth $355K as of Q2 2026.
  • Financial Security Advisor left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.06% of Financial Security Advisor's portfolio in Q2 2026, its #118 holding.
  • Financial Security Advisor first reported a position in Novartis in Q3 2023 and has held it in 12 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Financial Security Advisor's 13F filing for Q2 2026, filed 11 Aug 2026.